Drugs for HER-2-positive Breast Cancer V
โ
Sibilia, Maria; Zielinski, Christoph C.; Bartsch, Rupert; Grunt, Thomas W.
๐
Article
๐
2010
๐
Springer Basel
๐
German
โ 425 KB
Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best described membrane receptor tyrosine kinase family in malignant tumors. With implementation of the growth-inhibitory